币界网报道:Nasdaq-listed Prenetics announced that it has entered into a definitive agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Corporation for approximately $71.78 million. The divestiture of ACT Genomics significantly strengthens Prenetics' financial foundation, with estimated cash reserves of approximately $86 million and estimated cash and short-term assets of $117 million. The Company maintains a debt-free balance sheet with zero debt, allowing it to explore alternative financial management options, including digital asset adoption and Bitcoin financial strategies.